1. Combined immunity of DNA vector and recombinant vaccinia virus expressing Gag proteins of equine infectious anemia virus
- Author
-
Shao Yiming, Dai Chunming, Duan Dan-li, Wang Shuhui, Shen Rong-xian, Zhang Xiao-yan, and Liu Ying
- Subjects
Virus quantification ,Multidisciplinary ,biology ,animal diseases ,viruses ,biochemical phenomena, metabolism, and nutrition ,Group-specific antigen ,biology.organism_classification ,Recombinant virus ,Virology ,Molecular biology ,Virus ,law.invention ,Equine infectious anemia ,chemistry.chemical_compound ,chemistry ,law ,Recombinant DNA ,Vaccinia ,Homologous recombination - Abstract
In order to develop a new vaccine candidate for equine infectious anemia virus (EIAV), gag gene of Chinese donkey leukocyte attenuated strain (EIAV DLV) and its parental virulent strain (EIAV LN) were inserted respectively into the TK region of the Tiantan strain (VV) of vaccinia virus by homologous recombination and the positive clone was confirmed by blue plaque assay. Protein expression was examined by Western blot. Prime and prime-boost procedures were used to immunize mice with two DNA vectors and two recombinant vaccinia viruses expressing EIAV Gag proteins. The results showed that the specific lysis of CTL responses in the DNA+rVV groups was stronger than those in the DNA groups, amounting to 31%. Although the levels of specific antibodies were not significantly different, we could conclude that the recombinant vaccinia virus could boost the cellular responses following DNA vector priming. There was no detectable difference between the immune responses induced by DLV and LN Gag proteins. This data demonstrates that the combined immunity of DNA vector and recombinant vaccinia virus expressing EIAV gag proteins, utilizing the prime-boost procedure, can drive immunized mice to produce powerful cellular responses. These results lay an important foundation for the development of a new EIAV genetic engineering vaccine.
- Published
- 2004